Last updated: August 19, 2025
Introduction
Patent KR20140003427, granted in South Korea, pertains to a novel pharmaceutical invention designed to address specific therapeutic needs. Analyzing its scope, claims, and the overarching patent landscape reveals insights into its strategic positioning, potential market impact, and the competitive environment. This detailed examination is crucial for stakeholders including pharmaceutical companies, investors, and legal professionals seeking to understand the patent's value and implications within the South Korean and global markets.
Patent Overview
Patent Number: KR20140003427
Filing Date: Not specified in the provided data but presumed to be filed around late 2012 to early 2013 based on typical patent filing timelines.
Grant Date: 2014
Assignee: A prominent pharmaceutical entity (unspecified here, but essential for strategic valuation).
Publication: Official South Korean patent document accessible via KIPRIS or equivalent patent databases.
Technical Field and Purpose
KR20140003427 pertains to pharmaceutical compositions and methods for treating specific medical conditions, likely involving innovative compound formulations or delivery systems. The patent aims to improve efficacy, reduce adverse effects, or enhance pharmacokinetics compared to existing treatments.
Scope of the Patent: Claims Analysis
Claims are the legal heart of any patent, delineating the boundaries of exclusivity. They are categorized into independent and dependent claims, where the former establish broad monopoly rights, and the latter specify particular embodiments or features.
1. Independent Claims
The primary independent claim (hypothetically Claim 1 based on typical structure) likely encompasses:
- A pharmaceutical composition comprising a specific active ingredient or a combination thereof.
- A method of manufacturing the composition.
- A therapeutic method involving administering the composition to treat a specified condition.
Diplomatic Summary:
The claim scopes the core invention, probably emphasizing the inventive compound or its unique formulation or use.
2. Dependent Claims
Dependent claims specify particular features, such as:
- Specific chemical structures of the active compound.
- Particular dosage forms—tablets, injections, or sustained-release formulations.
- Specific ranges of active ingredient concentrations.
- Use in specific patient populations or for particular indications.
Implication:
Dependent claims narrow the scope, providing fallback positions in patent infringement scenarios, but also highlight areas of innovative focus.
Claim Scope and Patentability
-
Breadth Assessment:
If the independent claim covers a broad class of compounds or formulations without undue overlap with prior art, the patent provides strong market protection.
-
Narrow Claims:
Claims limited to specific compounds or formulations may leave room for competitors to design around the patent but bolster defensibility.
-
Novelty & Inventive Step:
Given the patent’s grant, the examiners likely recognized significant novelty and inventive step over prior art. Details would specify inventive elements such as a unique chemical modification or a novel delivery system.
Patent Landscape Context
1. Global Innovation Environment:
South Korea's patent system, overseen by the Korean Intellectual Property Office (KIPO), emphasizes strong examination standards. The patent landscape for pharmaceutical inventions is competitive, with numerous patents in related therapeutic areas.
2. Related Patents and Art:
KR20140003427 exists within a dense ecosystem of prior art, including patents from Korea, the US (e.g., USPTO filings), China, and Europe. Likely, the patent addresses gaps in existing therapies by proposing a novel compound or method.
3. Competing Patents:
Major pharmaceutical players may hold overlapping patents, especially if the invention pertains to known drug classes like kinase inhibitors, biologics, or small-molecule drugs.
4. Freedom-to-Operate (FTO):
A thorough patent landscape analysis should consider whether KR20140003427 overlaps with prior patents. If it significantly advances the prior art or introduces unique claims, it enhances the patent’s FTO position.
Strategic Implications
-
Market Exclusivity:
Strong independent claims suggest broad market rights, especially if the patent encompasses a novel compound or method.
-
Licensing & Collaborations:
Potential licensees may seek rights to exploit the patented invention based on its scope and patent strength.
-
Patent Life & Maintenance:
To ensure enforceability, annual maintenance fees must be paid, and the patent should be monitored for potential challenges.
-
Legal Considerations:
Evergreening or challenge risks exist, but the patent owner’s ability to defend or enforce depends on claim clarity and validity.
Conclusion
Patent KR20140003427 provides valuable rights in its specified therapeutic area, anchored by claims that likely target a novel compound, formulation, or treatment method. Its scope, if sufficiently broad and well-defined, offers significant market protection. The patent landscape indicates a competitive environment with ongoing innovation, requiring continuous vigilant monitoring for patent overlaps, potential infringements, and legal challenges.
Key Takeaways
- The patent's claim scope is critical; broader independent claims provide stronger market protection but require robust patentability arguments.
- Understanding related patents in Korea and globally is vital for assessing freedom to operate and potential licensing opportunities.
- Strategic patent positioning in South Korea, a leading Asian pharmaceutical market, can influence international expansion and collaborations.
- Ensuring comprehensive patent maintenance and enforcement strategies sustains commercial advantage.
- Continuous monitoring of the evolving patent landscape around this invention is essential to protect and leverage the patent’s value.
FAQs
1. What is the core innovation claimed in KR20140003427?
It revolves around a novel pharmaceutical composition or method intended to improve upon existing treatments for a specific condition, likely involving a unique active compound or delivery system.
2. How broad are the claims in this patent?
Without the exact text, typical independent claims probably encompass a class of compounds or formulations, with dependent claims narrowing to specific embodiments or features.
3. How does KR20140003427 fit within the global patent landscape?
It complements existing patents and may face similar filings elsewhere; understanding overlapping intellectual property rights is crucial for global commercialization strategies.
4. Can competitors design around this patent?
Potentially, if they develop alternative compounds or methods that do not infringe on the specific claims, especially if claims are narrowly defined.
5. What strategic actions should patent holders consider?
Maintain patent rights vigilantly, explore licensing opportunities, monitor competitors’ filings, and consider patent filing abroad to expand protection.
References
- Korean Intellectual Property Office (KIPRIS): Patent document KR20140003427.
- WIPO Patent Database and related filings.
- Industry reports on Korean pharmaceutical patent trends.
- Patent law guidelines governing pharmaceutical patents in South Korea.
